CareDx, Inc. files with the SEC under CIK 0001217234 and is classified as medical laboratories. We track it alongside the rest of the Health Care sector.
Footnote F2 (price): The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR
Footnote F1 (price): The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.96 to $21.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR
Footnote F2 (price): The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.73 to $20.105 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR
Footnote F2 (price): The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.405 to $21.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR
Footnote F1 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F1 (shares): The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to… Full note on SEC EDGAR
Footnote F1 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F1 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F1 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F1 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F1 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F1 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F1 (shares): Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.
Footnote F1 (shares): The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to… Full note on SEC EDGAR
Footnote F2 (shares): The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human… Full note on SEC EDGAR
Footnote F3 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs.
Footnote F1 (shares): The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to… Full note on SEC EDGAR
Footnote F2 (shares): The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human… Full note on SEC EDGAR
Footnote F3 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs.
Footnote F1 (shares): The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to… Full note on SEC EDGAR
Footnote F2 (shares): The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human… Full note on SEC EDGAR
Footnote F3 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs.
Footnote F1 (shares): The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to… Full note on SEC EDGAR
Footnote F2 (shares): The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human… Full note on SEC EDGAR
Footnote F3 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs.
Footnote F4 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of RSUs.
Footnote F1 (shares): The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to… Full note on SEC EDGAR
Footnote F2 (shares): The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human… Full note on SEC EDGAR
Footnote F3 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs.
Footnote F2 (price): The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.43 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR
Footnote F2 (price): The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR
Footnote F1 (shares): Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.
Footnote F2 (price): The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.69 to $19.67 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR
Footnote F3 (price): The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.73 to $19.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of… Full note on SEC EDGAR
Footnote F1 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F1 (shares): These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Footnote F1 (shares): The reported securities are represented by restricted stock units ("RSUs"), which vest in equal annual installments, such that one-hundred percent of the RSUs will be vested on the third anniversary of October 22, 2025, subject to the Reporting Person's continuous service on… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
Footnote F1 (shares): Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.
An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
CareDx, Inc. (CDNA) had 14 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for CDNA runs to 101 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CDNA stock?
No insider purchases of CDNA were filed in the last 90 days.
How many insiders are selling CDNA stock?
9 insider sales of CDNA were filed in the last 90 days, totaling $9.40M.
Where can I see CDNA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CDNA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.